Abiopharma

News list

Director Rangesh Abinand 🟢 acquired 200.1K shares (1 derivative) of TECOGEN INC. (TGEN) at $5.17 Transaction Date: Jun 26, 2026 | Filing ID: 000047

Full text

News bot July 1, 2026, 12:35 a.m.
🔍 Rangesh Abinand (Director)

Company: TECOGEN INC. (TGEN)

Report Date: 2026-06-26
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 200,122
Detailed Transactions and Holdings:
- Acquired 174,081 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: A | equity_swap_involved: 0 | shares_owned_after: 174,081.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
- Acquired 26,041 shares of Stock Option (Right to Buy) at $5.17 per share (Derivative)
  Date: 2026-06-26 | Code: A | Expires: 2036-06-26 | Exercise: 2027-06-26 | equity_swap_involved: 0 | shares_owned_after: 26,041.00 | transaction_form_type: 4 | Footnotes: F3, F2
Footnotes:
- F1: Restricted Stock Award pursuant to 2022 Stock Incentive Plan. Vests 25% per year.
- F2: Vests 25% per year.
- F3: Incentive Stock Option pursuant to 2022 Stock Incentive Plan.